ICT&health February 22, 2021
Mehdi Khaled | Managing Partner of Seha

The great momentum being generated by Digital Therapeutics (DTx) in North America and Europe is second to no other digital health segment today. Indeed, the ripple effects emanating from the German DiGA Framework are already being felt in Belgium, Spain, and Italy, with more countries to come.

Furthermore, the addition of a €5.1B EU-financial boost to accelerate digital innovation, and interoperability adoption makes Europe the new Digital Health Mecca for 2021 and beyond. However, with so much funding, innovation, and encouraging policies, the responsibility is also to prove positive socio-economic impact and health outcomes.

Pit-Stop

As DTx is still taking baby steps to higher maturity and adoption levels, it’s a good time for a pit-stop to reassess the broader DTx...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Pharma / Biotech, Precision Medicine
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article